Perioperative Durvalumab Appears Safe for Locally Advanced RCC

(MedPage Today) -- While checkpoint inhibitors are a safe and effective treatment option in metastatic renal cell carcinoma (RCC), effective neoadjuvant and adjuvant therapies are lacking in locally advanced disease. At the 2020 American Society...